Evidence map›Paper›PMID 37834391›Full record

ArticleInternational journal of molecular sciences2023

Four-and-a-Half LIM-Domain Protein 2 (FHL2) Induces Neuropeptide Y (NPY) in Macrophages in Visceral Adipose Tissue and Promotes Diet-Induced Obesity.

Judith Sommer, Hanna Ehnis, Tatjana Seitz, Julia Schneider, Andreas B Wild, Sandra Moceri, Christa Buechler, Aline Bozec, Georg F Weber, Susanne Merkel and 9 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. The miRNomics of antiretroviral therapy-induced obesity.Functional & integrative genomics · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Judith SommerInstitute of Biochemistry, Friedrich-Alexander-University Erlangen-Nürnberg, Fahrstr. 17, D-91054 Erlangen, Germany.ORCID 0009-0006-8311-6413
Hanna EhnisInstitute of Biochemistry, Friedrich-Alexander-University Erlangen-Nürnberg, Fahrstr. 17, D-91054 Erlangen, Germany.
Tatjana SeitzInstitute of Biochemistry, Friedrich-Alexander-University Erlangen-Nürnberg, Fahrstr. 17, D-91054 Erlangen, Germany.
Julia SchneiderInstitute of Biochemistry, Friedrich-Alexander-University Erlangen-Nürnberg, Fahrstr. 17, D-91054 Erlangen, Germany.
Andreas B WildDepartment of Immune Modulation, University Hospital Erlangen, Hartmannstr. 4, D-91052 Erlangen, Germany.ORCID 0009-0005-6008-2874
Sandra MoceriDepartment of Experimental Therapy, Preclinical Experimental Center, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Palmsanlage 5, D-91054 Erlangen, Germany.
Christa BuechlerDepartment of Internal Medicine I, University Hospital of Regensburg, Franz-Josef-Strauß-Allee 11, D-93053 Regensburg, Germany.ORCID 0000-0002-5635-3994
Aline BozecDepartment of Internal Medicine 3, Rheumatology and Immunology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Glückstr. 6, D-91054 Erlangen, Germany.
Georg F WeberDepartment of Surgery, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Krankenhausstr. 12, D-91054 Erlangen, Germany.ORCID 0000-0003-1175-4505
Susanne MerkelDepartment of Surgery, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Krankenhausstr. 12, D-91054 Erlangen, Germany.ORCID 0000-0003-2676-9486
Ruth BeckervordersandforthInstitute of Biochemistry, Friedrich-Alexander-University Erlangen-Nürnberg, Fahrstr. 17, D-91054 Erlangen, Germany.
Alexander SteinkassererDepartment of Immune Modulation, University Hospital Erlangen, Hartmannstr. 4, D-91052 Erlangen, Germany.
Roland SchüleCenter for Clinical Research, University of Freiburg Medical School, Breisacherstr. 66, D-79106 Freiburg, Germany.
Jonel TrebickaDepartment of Internal Medicine B, University of Münster, Albert-Schweitzer-Campus 1, D-48149 Münster, Germany.
Arndt HartmannInstitute of Pathology, Friedrich-Alexander-University Erlangen-Nürnberg, Krankenhausstr. 8/10, D-91054 Erlangen, Germany.
Anja BosserhoffInstitute of Biochemistry, Friedrich-Alexander-University Erlangen-Nürnberg, Fahrstr. 17, D-91054 Erlangen, Germany.ORCID 0000-0001-8147-394X
Stephan von HörstenDepartment of Experimental Therapy, Preclinical Experimental Center, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Palmsanlage 5, D-91054 Erlangen, Germany.ORCID 0000-0001-6409-0664
Peter DietrichInstitute of Biochemistry, Friedrich-Alexander-University Erlangen-Nürnberg, Fahrstr. 17, D-91054 Erlangen, Germany.ORCID 0000-0003-2289-8600
Claus HellerbrandInstitute of Biochemistry, Friedrich-Alexander-University Erlangen-Nürnberg, Fahrstr. 17, D-91054 Erlangen, Germany.ORCID 0000-0001-9472-4461
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEUniversitätsklinikum Erlangen · DEUniversity Hospital Regensburg · DEUniversity of Freiburg · DEUniversity of Münster · DE

Funding

Deutsche Forschungsgemeinschaft HE 2458/20-1
6 · The paper itself

Abstract

Obesity is characterized by the expansion of the adipose tissue, usually accompanied by inflammation, with a prominent role of macrophages infiltrating the visceral adipose tissue (VAT). This chronic inflammation is a major driver of obesity-associated comorbidities. Four-and-a-half LIM-domain protein 2 (FHL2) is a multifunctional adaptor protein that is involved in the regulation of various biological functions and the maintenance of the homeostasis of different tissues. In this study, we aimed to gain new insights into the expression and functional role of FHL2 in VAT in diet-induced obesity. We found enhanced FHL2 expression in the VAT of mice with Western-type diet (WTD)-induced obesity and obese humans and identified macrophages as the cellular source of enhanced FHL2 expression in VAT. In mice with FHL2 deficiency (FHL2

Indexed as

Intra-Abdominal FatNeuropeptide YAdipose TissueAnimalsDietDiet, High-FatHumansInflammationLIM-Homeodomain ProteinsLipidsMacrophagesMiceMice, Inbred C57BLMuscle ProteinsObesityTranscription FactorsFHL2 protein, humanFhl2 protein, mouseLIM-Homeodomain ProteinsLipidsMuscle ProteinsNeuropeptide YTranscription FactorsadipocytesFHL2macrophagesMCP-1NPYobesitythermogenesis

Identifiers

PMID37834391
PMCPMC10573629
OpenAlexW4387401079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.